Lasa Supergenerics Limited has reported Standalone financial results for the period ended June 30, 2023.
Financial Results (Q1 FY2024) - QoQ Comparison
The company has reported total income of Rs. 30.5598 crores during the period ended June 30, 2023 as compared to Rs. 36.2544 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs. -4.9496 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -15.0008 crores for the period ended March 31, 2023.
The company has reported EPS of Rs. -0.99 for the period ended June 30, 2023 as compared to Rs. -2.99 for the period ended March 31, 2023.
Total Income | ₹ 30.5598 crs | ₹36.2544 crs | -15.71% |
Net Profit | ₹-4.9496 crs | ₹-15.0008 crs | 67.00% |
EPS | ₹-0.99 | ₹-2.99 | 66.89% |
Financial Results (Q1 FY2024) - YoY Comparison The company has reported total income of Rs. 30.5598 crores during the period ended June 30, 2023 as compared to Rs.28.8874 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs.-4.9496 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.-12.0839 crores for the period ended June 30, 2022.
The company has reported EPS of Rs.-0.99 for the period ended June 30, 2023 as compared to Rs.-2.97 for the period ended June 30, 2022.
Total Income | ₹ 30.5598 crs | ₹28.8874 crs | 5.79% |
Net Profit | ₹-4.9496 crs | ₹-12.0839 crs | 59.04% |
EPS | ₹-0.99 | ₹-2.97 | 66.67% |
Shares of Lasa Supergenerics Limited was last trading in BSE at Rs. 24.88 as compared to the previous close of Rs. 24.76. The total number of shares traded during the day was 15708 in over 151 trades.
The stock hit an intraday high of Rs. 25.10 and intraday low of 24.05. The net turnover during the day was Rs. 388722.00.
Source : Equity Bulls
Keywords
LasaSupergenerics
Q1FY24
ResultUpdate